CTRI/2024/07/069866尚未招募2 期
Open label randomised controlled trial of telmisartan in Raynauds phenomena associated with progressive systemic sclerosis and mixed connective tissue disorder - NI
Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 2210050 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age greater than or equal to 18 years
- •2.Patients diagnosed as systemic sclerosis or MCTD with history of Raynauds Phenomena
- •3.Willing to give signed written consent
排除标准
- •1.Any co-existing significant/incapacitating chronic illness
- •2.Patient with symptomatic CAD
- •3.Patients on oral or sublingual nitrates
- •4.Patient who are pregnant or reproductive couples who have intention of pregnancy
- •5.Patients with known contraindication to either of IPs or SOC
- •Patient with symptomatic CAD
研究者
相似试验
尚未招募
2 期
To check the efficacy if Telmisartan in Raynauds phenomenon associated with Systemic Lupus Erythematosus and Rheumatoid ArthritisCTRI/2024/07/069868Institute of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 221005
尚未招募
4 期
Randomized clinical trial on efficacy of telmisartan compared to vitamin E on histopathological improvement in patients with nonalcoholic steatohepatitis.onalcoholic steatohepatitis (NASH)SLCTR/2016/013Bangabandhu Sheikh Mujib Medical University
已完成
不适用
se of sedating antidepressant to reduce the benzodiazepine use in patients with depressioCTRI/2022/08/044959Drashti Manishbhai Shah60
已完成
不适用
Open label, randomized controlled trial of Pemafibrate to evaluate renopotective effect in CKD patientschronic renal failure, dyslipidemiaJPRN-UMIN000042284kyushu university140
尚未招募
Unknown
A study to evaluate the efficacy of Haritakyadi Kwatha in the management of Pittaja MutrakrichraCTRI/2023/06/053645Dr Akash Gupta